TY - JOUR
T1 - Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn — A single-center, 5-year experience
AU - Gupta, Anju
AU - Rastogi, Shantanu
AU - Sahni, Rakesh
AU - Bhutada, Alok
AU - Bateman, David
AU - Rastogi, Deepa
AU - Smerling, Arthur
AU - Wung, Jen Tien
PY - 2002
Y1 - 2002
N2 - Objective. To evaluate the effect of inhaled nitric oxide (INO) in pulmonary hypertension of the newborn (PH) in a single center over 5 years using gentle ventilation (GV), without hyperventilation or induced alkalosis. Methods: Data from 229 consecutive infants with PH of varied etiology treated with INO and GV, and from 67 infants with meconium aspiration syndrome (MAS) and primary PH (PPHN) treated with GV alone were reviewed over a 5-year period (86% outborn). INO was initiated at 25 ppm when PH and severe hypoxemia persisted despite maximal optimal ventilation. Hyper-ventilation or systemic alkalosis were not attempted. Results: Mean duration of ventilation was 9.9 ± 14 days (median 6.5 days). Average mean airway pressure (MAP) dropped from 17.7 ± 4.3 cm H2O at the referral hospital to 13.2 ± 2.5 cm H2O (p < 0.001) following admission to our unit using conventional settings and GV, before starting INO. Mean oxygenation index (OI) dropped from 46.8 ± 24.5 to 22.7 ± 21.4 within 24 hours of INO therapy (p < 0.001). Infants with higher baseline pH and lower baseline OI responded better to INO (p < 0.02). Overall survival was 72%. Patients with MAS and PPHN had the best response, 92% survived and there was a 46% reduction in need for extracorporeal membrane oxygenation (ECMO) compared to historical pre-INO period controls (23.9% vs. 12.8%, p < 0.01). In the infants treated with GV alone, the MAP dropped from 17.2 ± 4.3 cm H2O at the referral hospital to 12.6 ± 2.4 after GV was started in our unit. Conclusions: We conclude that INO is an effective and well-tolerated therapy for PH in infants receiving GV.
AB - Objective. To evaluate the effect of inhaled nitric oxide (INO) in pulmonary hypertension of the newborn (PH) in a single center over 5 years using gentle ventilation (GV), without hyperventilation or induced alkalosis. Methods: Data from 229 consecutive infants with PH of varied etiology treated with INO and GV, and from 67 infants with meconium aspiration syndrome (MAS) and primary PH (PPHN) treated with GV alone were reviewed over a 5-year period (86% outborn). INO was initiated at 25 ppm when PH and severe hypoxemia persisted despite maximal optimal ventilation. Hyper-ventilation or systemic alkalosis were not attempted. Results: Mean duration of ventilation was 9.9 ± 14 days (median 6.5 days). Average mean airway pressure (MAP) dropped from 17.7 ± 4.3 cm H2O at the referral hospital to 13.2 ± 2.5 cm H2O (p < 0.001) following admission to our unit using conventional settings and GV, before starting INO. Mean oxygenation index (OI) dropped from 46.8 ± 24.5 to 22.7 ± 21.4 within 24 hours of INO therapy (p < 0.001). Infants with higher baseline pH and lower baseline OI responded better to INO (p < 0.02). Overall survival was 72%. Patients with MAS and PPHN had the best response, 92% survived and there was a 46% reduction in need for extracorporeal membrane oxygenation (ECMO) compared to historical pre-INO period controls (23.9% vs. 12.8%, p < 0.01). In the infants treated with GV alone, the MAP dropped from 17.2 ± 4.3 cm H2O at the referral hospital to 12.6 ± 2.4 after GV was started in our unit. Conclusions: We conclude that INO is an effective and well-tolerated therapy for PH in infants receiving GV.
UR - http://www.scopus.com/inward/record.url?scp=0036708232&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036708232&partnerID=8YFLogxK
U2 - 10.1038/sj.jp.7210761
DO - 10.1038/sj.jp.7210761
M3 - Article
C2 - 12168118
AN - SCOPUS:0036708232
SN - 0743-8346
VL - 22
SP - 435
EP - 441
JO - Journal of Perinatology
JF - Journal of Perinatology
IS - 6
ER -